James H Cavanaugh Leap Therapeutics, Inc. (LPTX) insider trading activity
James H Cavanaugh is Director of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 213 shares of LPTX, which is worth approximately $619. The most recent transaction as insider was on Nov 13, 2024, when has been sold 213 shares (Common Stock) at a price of $2.82 per share, resulting in proceeds of $600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
213
n/a
3M change
n/a
12M change
Total Value Held
$619
JHC
James H Cavanaugh
Director
Cambridge, MA